| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4007685
[patent_doc_number] => 05859308
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Transgenic animals and related aspects'
[patent_app_type] => 1
[patent_app_number] => 8/365966
[patent_app_country] => US
[patent_app_date] => 1994-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 19
[patent_no_of_words] => 13564
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/859/05859308.pdf
[firstpage_image] =>[orig_patent_app_number] => 365966
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/365966 | Transgenic animals and related aspects | Dec 28, 1994 | Issued |
Array
(
[id] => 3480177
[patent_doc_number] => 05457046
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-10-10
[patent_title] => 'Enzyme capable of degrading cellullose or hemicellulose'
[patent_app_type] => 1
[patent_app_number] => 8/361920
[patent_app_country] => US
[patent_app_date] => 1994-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16840
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/457/05457046.pdf
[firstpage_image] =>[orig_patent_app_number] => 361920
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/361920 | Enzyme capable of degrading cellullose or hemicellulose | Dec 21, 1994 | Issued |
Array
(
[id] => 3840932
[patent_doc_number] => 05707865
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-13
[patent_title] => 'Retroviral vectors for expression in embryonic cells'
[patent_app_type] => 1
[patent_app_number] => 8/361112
[patent_app_country] => US
[patent_app_date] => 1994-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 7843
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/707/05707865.pdf
[firstpage_image] =>[orig_patent_app_number] => 361112
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/361112 | Retroviral vectors for expression in embryonic cells | Dec 20, 1994 | Issued |
Array
(
[id] => 3696277
[patent_doc_number] => 05650503
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-22
[patent_title] => 'Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals'
[patent_app_type] => 1
[patent_app_number] => 8/359854
[patent_app_country] => US
[patent_app_date] => 1994-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 17016
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/650/05650503.pdf
[firstpage_image] =>[orig_patent_app_number] => 359854
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/359854 | Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals | Dec 19, 1994 | Issued |
| 08/346129 | DIAGNOSIS OF AND THERAPY FOR HEREDITARY HAEMORRHAGIC TELANGIECTASIA | Nov 28, 1994 | Abandoned |
| 08/348258 | TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS | Nov 27, 1994 | Abandoned |
Array
(
[id] => 4033519
[patent_doc_number] => 05856153
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases'
[patent_app_type] => 1
[patent_app_number] => 8/343923
[patent_app_country] => US
[patent_app_date] => 1994-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9551
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856153.pdf
[firstpage_image] =>[orig_patent_app_number] => 343923
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/343923 | Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases | Nov 16, 1994 | Issued |
Array
(
[id] => 3982271
[patent_doc_number] => 05861299
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals'
[patent_app_type] => 1
[patent_app_number] => 8/343884
[patent_app_country] => US
[patent_app_date] => 1994-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 31
[patent_no_of_words] => 17016
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861299.pdf
[firstpage_image] =>[orig_patent_app_number] => 343884
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/343884 | Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals | Nov 16, 1994 | Issued |
Array
(
[id] => 3882444
[patent_doc_number] => 05714170
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-03
[patent_title] => 'Method of inducing resistance to tumor growth'
[patent_app_type] => 1
[patent_app_number] => 8/340732
[patent_app_country] => US
[patent_app_date] => 1994-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6400
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/714/05714170.pdf
[firstpage_image] =>[orig_patent_app_number] => 340732
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/340732 | Method of inducing resistance to tumor growth | Nov 15, 1994 | Issued |
| 08/340826 | METHODS FOR INHIBITING CELL PROLIFERATION BY INHIBITING THE MITOGENIC ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR | Nov 15, 1994 | Abandoned |
Array
(
[id] => 3728808
[patent_doc_number] => 05652217
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => 'Fibronectin binding protein'
[patent_app_type] => 1
[patent_app_number] => 8/340458
[patent_app_country] => US
[patent_app_date] => 1994-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4935
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/652/05652217.pdf
[firstpage_image] =>[orig_patent_app_number] => 340458
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/340458 | Fibronectin binding protein | Nov 13, 1994 | Issued |
Array
(
[id] => 3767153
[patent_doc_number] => 05773268
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Chromosome 21 gene marker, compositions and methods using same'
[patent_app_type] => 1
[patent_app_number] => 8/337690
[patent_app_country] => US
[patent_app_date] => 1994-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 9508
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773268.pdf
[firstpage_image] =>[orig_patent_app_number] => 337690
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/337690 | Chromosome 21 gene marker, compositions and methods using same | Nov 8, 1994 | Issued |
| 08/336534 | GENE THERAPY FOR HYPERCHOLESTEROLEMIA | Nov 8, 1994 | Abandoned |
| 08/335461 | ENHANCING THE SENSITIVITY OF TUMOR CELLS TO THERAPIES | Nov 6, 1994 | Abandoned |
| 08/334567 | INSECTICIDAL COMPOSITION CONTAINING HETERORHABDITIS NEMATODES AND PROCESS | Nov 3, 1994 | Abandoned |
Array
(
[id] => 3668090
[patent_doc_number] => 05599906
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-04
[patent_title] => 'Protease assays'
[patent_app_type] => 1
[patent_app_number] => 8/333901
[patent_app_country] => US
[patent_app_date] => 1994-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8119
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/599/05599906.pdf
[firstpage_image] =>[orig_patent_app_number] => 333901
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/333901 | Protease assays | Nov 2, 1994 | Issued |
Array
(
[id] => 3589032
[patent_doc_number] => 05552528
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-03
[patent_title] => 'Bovine b-endothelial cell growth factor'
[patent_app_type] => 1
[patent_app_number] => 8/334884
[patent_app_country] => US
[patent_app_date] => 1994-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 8547
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/552/05552528.pdf
[firstpage_image] =>[orig_patent_app_number] => 334884
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/334884 | Bovine b-endothelial cell growth factor | Nov 2, 1994 | Issued |
Array
(
[id] => 3586795
[patent_doc_number] => 05550041
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-27
[patent_title] => 'Caffeine demethylate gene-containing DNA fragment and microbial process for producing 3-methyl-7-alkylxanthine'
[patent_app_type] => 1
[patent_app_number] => 8/324483
[patent_app_country] => US
[patent_app_date] => 1994-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9015
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/550/05550041.pdf
[firstpage_image] =>[orig_patent_app_number] => 324483
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/324483 | Caffeine demethylate gene-containing DNA fragment and microbial process for producing 3-methyl-7-alkylxanthine | Oct 17, 1994 | Issued |
| 08/323490 | TRANSGENIC NONHUMAN ANIMAL HAVING FUNCTIONALLY DISRUPTED INTERLEUKIN-1BETA CONVERTING ENZYME GENE | Oct 13, 1994 | Abandoned |
Array
(
[id] => 3936407
[patent_doc_number] => 05981277
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology'
[patent_app_type] => 1
[patent_app_number] => 8/318837
[patent_app_country] => US
[patent_app_date] => 1994-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 34
[patent_no_of_words] => 29381
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981277.pdf
[firstpage_image] =>[orig_patent_app_number] => 318837
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/318837 | Polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology | Oct 12, 1994 | Issued |